Updated:
Radius Ventures
Radius Ventures is a venture capital firm that invests in growth equity and expansion-stage health and life sciences companies. The firm is led by a group of...
Radius Ventures
Radius Ventures is a venture capital firm that invests in growth equity and expansion-stage health and life sciences companies. The firm is led by a group of investment professionals with experience across medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company, providing intellectual capital, strategic guidance and access to industry relationships.
General information
Firm type
Venture Capital
Year founded
1997
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Jordan S. Davis
Managing Partner and Co-founder
Daniel C. Lubin
Managing Partner and Co-Founder
Neenah Jain
Chief Financial Officer
Sector focus
Frequently asked questions
Is Radius Ventures still investing?
No. Radius Ventures completed its active investment period and wound down operations in 2024, as stated on its website. The firm's final and largest fund, Radius Venture Partner III, LP, achieved top-quartile performance relative to the Cambridge Associates Q3 2024 Venture Capital Index. The co-founders have since moved on to separate vehicles: Jordan Davis formed JSD Capital and Radius Special Situations, while Daniel Lubin formed Upsher Management Company.
What did Radius Ventures invest in?
Radius targeted venture-stage healthcare companies across diagnostics, medical technology, therapeutics, and health IT. The firm backed more than 40 companies over 27 years, with realized exits including Conor Medsystems (IPO, then acquired by Johnson & Johnson), U-Systems (acquired by GE Healthcare), Tactile Medical (IPO), BioStorage Technologies (acquired by Brooks Automation), and Health Language (acquired by Wolters Kluwer Health).
Who ran investment decisions at Radius Ventures?
Co-founders Jordan S. Davis and Daniel C. Lubin served as Managing Partners from the firm's 1997 launch through its 2024 wind-down, leading all investment decisions. They were supported by a group of Venture Partners that included former Pfizer R&D President George Milne, PhD; former Cleveland Clinic CEO Floyd Loop, MD (deceased); former Maine Medical Center President Vincent Conti; and former Capital BlueCross CEO James Mead.
What was the scale of the final Radius fund?
Radius Ventures did not publicly disclose the size of Radius Venture Partner III, LP. The firm stated on its website that the fund achieved top-quartile performance, citing Cambridge Associates' Q3 2024 Venture Capital Index and Benchmark Statistics, but no dollar figure for commitments or net asset value is available in the public record.
Where does the underlying wealth come from?
Radius Ventures was structured as an independent private equity and venture capital partnership, not a family office or the investment arm of a corporation. The firm's capital came from external limited partners across its fund vehicles. The personal wealth of its co-founders, Jordan Davis and Daniel Lubin, derives principally from carried interest and management fees earned over the firm's 27-year history.
How is Radius Ventures related to JSD Capital and Upsher Management Company?
Following Radius' 2024 wind-down, co-founder Jordan Davis established JSD Capital and Radius Special Situations to pursue healthcare structured-equity and credit opportunities, while co-founder Daniel Lubin launched Upsher Management Company. These are successor entities operating independently, not affiliates of the original Radius Ventures partnership, which is no longer making new investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: